论文部分内容阅读
由中国药学会应用药理专业委员会和中国药理学会制药工业专业委员会联合主办,中国药科大学、成都华西海圻医药科技有限公司(国家成都新药安全性评价中心)、西部药谷-眉山经济开发区新区管委会承办的创新药物成药性评价高层学术论坛定于2014年11月1日至3日在四川省眉山市召开。“创新药物成药性评价高层学术论坛”主要面向我国医药企业和新药研发科研院所的广大药学工作者。会议将通过特约报告和典型研发案例相结合,聚焦创新药物研发领域的新进展,介绍国内外成药性评价的前沿理念,探讨我国新药研发的国
By the Chinese Pharmacological Society of Pharmacology Committee and the Chinese Pharmacological Society of Pharmaceutical Industry Professional Committee co-sponsored by China Pharmaceutical University, Chengdu Huaxi Haigeng Pharmaceutical Technology Co., Ltd. (National Chengdu new drug safety evaluation center), western medicine Valley - Meishan Economic Development Zone New District Management Committee contractors innovative drug evaluation of medicinal high-level academic forum is scheduled for November 1, 2014 to 3 in Meishan City, Sichuan Province. “Innovative drug evaluation of medicinal high-level academic forum ” mainly for our pharmaceutical enterprises and research and development of new drug research and development of the majority of pharmacy workers. The conference will combine special reports with typical research and development cases to focus on new developments in the field of innovative drug research and introduction of cutting-edge concepts of drug evaluation at home and abroad to discuss the development of new drug research and development in China